Literature DB >> 18523795

Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system.

Wei Zhao1, Yu-Sheng Wang, Yan-Nian Hui, Jie Zhu, Peng Zhang, Xia Li, Guo-Rui Dou.   

Abstract

BACKGROUND: Retinal pigment epithelial (RPE) cells and choroidal microvascular endothelial cells (CECs) are the main cells involved in choroidal neovascularization (CNV), and hypoxia plays an important role in CNV formation via hypoxia inducible factor 1 (HIF-1). Our aim was to evaluate the role of HIF-1 in human RPE cells with regard to proliferation, migration and tube formation of CECs under hypoxia.
METHODS: RPE cells were cultured under chemical hypoxia induced by 200 muM CoCl(2), and RNA interference (RNAi) technique was used to knock down HIF-1alpha gene in RPE cells. mRNA and protein expression of HIF-1alpha and VEGF in RPE cells were investigated by real-time RT-PCR and Western blot. Three kinds of coculture models were used to observe the effects of RPE cells transfected by short hairpin RNA (shRNA)-expressing plasmid DNA (pDNA) (pshHIF-1alpha) on the proliferation, migration and tube formation of CECs respectively.
RESULTS: Transfection of shRNA-expressing pDNA targeting HIF-1alpha to RPE cells resulted in the knock down of HIF-1alpha gene and reduction of the corresponding mRNA and protein of HIF-1alpha and VEGF under hypoxia. Consequently, the proliferation, migration and tube formation of CECs were significantly inhibited by the knocked-down RPE cells compared with the control in the coculture system. The proliferation rates of CECs decreased by 40.2%, 36.6% and 36.8% on days 3, 4 and 5 respectively. Migration reduced by 49.6% at 5 h, and tube formation decreased by 40.4% at 48 h.
CONCLUSION: RNAi of HIF-1alpha in RPE cells can inhibit angiogenesis in vitro and provide a possible strategy for treatment of choroidal neovascularization diseases by targeting HIF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523795     DOI: 10.1007/s00417-008-0858-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Angiogenic pathways in diabetic retinopathy.

Authors:  Lloyd Paul Aiello
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

2.  Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion.

Authors:  Mark G Slomiany; Steven A Rosenzweig
Journal:  J Pharmacol Exp Ther       Date:  2006-05-08       Impact factor: 4.030

3.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Authors:  C Schwesinger; C Yee; R M Rohan; A M Joussen; A Fernandez; T N Meyer; V Poulaki; J J Ma; T M Redmond; S Liu; A P Adamis; R J D'Amato
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers.

Authors:  T Mizuno; M Nagao; Y Yamada; M Narikiyo; M Ueno; M Miyagishi; K Taira; Y Nakajima
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

Review 5.  Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.

Authors:  P A Campochiaro
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

6.  Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.

Authors:  Elizabeth W Newcomb; Yevgeniy Lukyanov; Tona Schnee; M Aktar Ali; Li Lan; David Zagzag
Journal:  Int J Oncol       Date:  2006-05       Impact factor: 5.650

7.  Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells.

Authors:  Yu-Sheng Wang; Wolfram Eichler; Ulrike Friedrichs; Yousef Yafai; Stephan Hoffmann; Tsutomu Yasukawa; Yan-Nian Hui; Peter Wiedemann
Journal:  Curr Eye Res       Date:  2005-06       Impact factor: 2.424

8.  Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

Authors:  Antoinette C Lambooij; Karel H M van Wely; Dicky J Lindenbergh-Kortleve; Robert W A M Kuijpers; Mike Kliffen; Cornelia M Mooy
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

9.  Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells.

Authors:  Peng Zhang; Yusheng Wang; Yannian Hui; Dan Hu; Haiyan Wang; Jian Zhou; Hongjun Du
Journal:  Ophthalmologica       Date:  2007       Impact factor: 3.250

10.  Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.

Authors:  Farzin Forooghian; Bikul Das
Journal:  Am J Ophthalmol       Date:  2007-09-17       Impact factor: 5.258

View more
  11 in total

1.  Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.

Authors:  R K Vadlapatla; A D Vadlapudi; D Pal; M Mukherji; A K Mitra
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

2.  Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells.

Authors:  Yuan-yuan Shi; Yu-sheng Wang; Zhao-xia Zhang; Yan Cai; Jing Zhou; Hui-yuan Hou; Nico van Rooijen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-06-08       Impact factor: 3.117

3.  Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.

Authors:  Nathan G Lambert; Xiaohui Zhang; Ruju R Rai; Hironori Uehara; Susie Choi; Lara S Carroll; Subrata K Das; Judd M Cahoon; Brian H Kirk; Blaine M Bentley; Balamurali K Ambati
Journal:  Exp Eye Res       Date:  2016-01-13       Impact factor: 3.467

4.  Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia.

Authors:  Peng Zhang; Xing Zhang; Xiaofeng Hao; Yusheng Wang; Yannian Hui; Haiyan Wang; Dan Hu; Jian Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-23       Impact factor: 3.117

5.  RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors.

Authors:  ChengShi Chen; JianHua Wang; Rong Liu; Sheng Qian
Journal:  Tumour Biol       Date:  2012-03-10

6.  The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.

Authors:  Qianying Gao; Wencong Wang; Yuqing Lan; Xiaoqing Chen; Wei Yang; Yongguang Yuan; Juan Tan; Yao Zong; Zhaoxin Jiang
Journal:  Int J Nanomedicine       Date:  2013-04-19

7.  Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.

Authors:  Xiao Dong; Yu-Sheng Wang; Guo-Rui Dou; Hui-Yuan Hou; Yuan-Yuan Shi; Rui Zhang; Ke Ma; Lin Wu; Li-Bo Yao; Yan Cai; Jian Zhang
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

8.  Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis.

Authors:  Sik-Won Choi; Kwang-Sik Lee; Jin Hwan Lee; Hyeon Jung Kang; Mi Ja Lee; Hyun Young Kim; Kie-In Park; Sun-Lim Kim; Hye Kyoung Shin; Woo Duck Seo
Journal:  BMB Rep       Date:  2016-09       Impact factor: 4.778

9.  Identification of a synergistic interaction between endothelial cells and retinal pigment epithelium.

Authors:  Carrie Spencer; Stephanie Abend; Kevin J McHugh; Magali Saint-Geniez
Journal:  J Cell Mol Med       Date:  2017-04-12       Impact factor: 5.310

10.  Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.

Authors:  Ji Ma; Yan Xue; Wenchao Liu; Caixia Yue; Feng Bi; Junqing Xu; Jian Zhang; Yan Li; Cuiping Zhong; Yan Chen
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.